Indication
Moraxella catarrhalis bronchitis
*Moraxella catarrhalis* bronchitis is a lower respiratory tract infection characterized by acute inflammation of the bronchial mucosa caused by the Gram-negative diplococcus *Moraxella catarrhalis*. Read more about Moraxella catarrhalis bronchitis
227 drugs 95 manufacturers
Drugs that treat it
Common Moraxella catarrhalis bronchitis therapies.
CEFPODOXIME PROXETIL
AMOXICILLIN-CLAVULANATE POTASS (amoxicillin/potassium clavulanate)
CIPROFLOXACIN-D5W (ciprofloxacin lactate/dextrose 5 % in water)
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Moraxella catarrhalis* bronchitis is a lower respiratory tract infection characterized by acute inflammation of the bronchial mucosa caused by the Gram-negative diplococcus *Moraxella catarrhalis*.
While acute tracheobronchitis can develop in immunocompromised hosts, this infection predominantly manifests as an acute bacterial exacerbation of chronic bronchitis in older adults and individuals with pre-existing chronic obstructive pulmonary disease (COPD) or compromised mucociliary clearance.
Pathophysiologically, colonization and mucosal invasion trigger neutrophil-mediated airway inflammation, clinically presenting with increased dyspnea, worsening cough, and a marked increase in sputum volume and purulence.
- nih.gov
*Moraxella catarrhalis* bronchitis is a lower respiratory tract infection characterized by acute inflammation of the bronchial mucosa caused by the Gram-negative diplococcus *Moraxella catarrhalis* While acute tracheobronchitis can develop in immunocompromised hosts, this infection predominantly manifests as an acute bacterial exacerbation of chronic bronchitis in older adults and individuals with pre-existing chronic obstructive pulmonary disease (COPD) or compromised mucociliary clearance
- merckmanuals.com
*Moraxella catarrhalis* bronchitis is a lower respiratory tract infection characterized by acute inflammation of the bronchial mucosa caused by the Gram-negative diplococcus *Moraxella catarrhalis* Pathophysiologically, colonization and mucosal invasion trigger neutrophil-mediated airway inflammation, clinically presenting with increased dyspnea, worsening cough, and a marked increase in sputum volume and purulence
- nih.gov
While acute tracheobronchitis can develop in immunocompromised hosts, this infection predominantly manifests as an acute bacterial exacerbation of chronic bronchitis in older adults and individuals with pre-existing chronic obstructive pulmonary disease (COPD) or compromised mucociliary clearance
- healthline.com
While acute tracheobronchitis can develop in immunocompromised hosts, this infection predominantly manifests as an acute bacterial exacerbation of chronic bronchitis in older adults and individuals with pre-existing chronic obstructive pulmonary disease (COPD) or compromised mucociliary clearance
- buffalo.edu
Pathophysiologically, colonization and mucosal invasion trigger neutrophil-mediated airway inflammation, clinically presenting with increased dyspnea, worsening cough, and a marked increase in sputum volume and purulence
- ajmc.com
Pathophysiologically, colonization and mucosal invasion trigger neutrophil-mediated airway inflammation, clinically presenting with increased dyspnea, worsening cough, and a marked increase in sputum volume and purulence
Personalize your experience
Follow Moraxella catarrhalis bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.